Summary
Hepatic encephalopathy in patients with severe liver disease was associated with marked elevation of either serum methionine or blood ammonia levels or with simultaneous moderate increases in both parameters. CSF methionine levels also increased in encephalopathic patients with fulminant hepatitis and liver cirrhosis. Increased influx of methionine into the brain over the theoretical values predicted from Pardridge’s equation suggested that accelerated transport of serum methionine across the blood-brain barrier was observed in these cases with hepatic encephalopathy.
Hepatic encephalopathy in acute carbon tetrachloride liver injury could be obtained experimentally following intraperitoneal injection of ammonium acetate in rats, which already received intragastric administration of methionine. However, similar encephalopathy could not be observed by the administration of glycine or leucine in place of methionine. These results suggest at least that methionine and ammonia act synergistically on inducing hepatic encephalopathy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Higashi T: Impaired metabolism of methionine in severe liver diseases. I. Clinical and pathophysiological significance of elevated serum methionine levels, (in press)
Watson CJ, et al: The prognosis and treatment of hepatic insufficiency. Ann Intern Med 31: 405, 1949
Chen S, et al: Mercaptans and dimethyl sulfide in the breath of patients with cirrhosis of the liver. J Lab Clin Med 75: 628, 1970
Zieve L, et al: Synergism between mercaptans and ammonia or fatty acids in the production of coma: A possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med 83: 16, 1974
Merino GE, et al: Methionine-induced hepatic coma in dogs. Am J Surg l30: 41, 1975
Fernstrom JD, et al: Brain serotonin content: Physiological regulation by plasma neutral amino acids. Science 178: 414, 1972
Pardridge WM, et al: Kinetic analysis of blood-brain barrier transport of amino acids. Biochim Biophy Acta 401: 128, 1975
Watanabe A, et al: Serum amino acids in hepatic encephalopathy -Effect of branched-chain amino acid infusion on serum aminogram. Acta Hepato-Gastroenterol 26: 346, 1979
Watanabe A, et al: An animal model of fulminant hepatic failure in the rat. Acta Med Okayama 33: 443, 1979
Phyllips GB, et al: The syndrome of impending hepatic coma in patients with cirrhosis of the liver given nitrogenous substances. New Engl J Med 247: 239, 1952
Takahashi Y: Serum lipids in liver disease. Liver disease and relationship of serum lipids and hepatic coma. Jpn J Gastroenterol 60: 571, 1963
Fischer JE, et al: Treatment of hepatic coma and hepatorenal syndrome. Mechanism of action of L-Dopa and aramin. Am J Surg 123: 222, 1972
Sherlock S, et al: Portal-systemic encephalopathy. Neurological complications of liver disease. Lancet II: 453, 1953
Smith AR, et al: Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg 187: 343, 1978
Virgilio L: Elevated cerebrospinal fluid glutamine and hepatic coma. Del Med J 44: 43, 1972
Hourani BT, et al: Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy. Arch Intern Med 127: 1033, 1971
Higashi T, et al: Effect of branched-chain amino acid infusion on alterations in CSF neutral amino acids and their transport across the blood-brain barrier in hepatic encephalopathy, in “Metabolism and clinical implications of branched-chain amino and ketoacids” by Elsevier North Holland, 1981, p 465
Ehrlich M, et al: Blood and brain ammonia concentrations after portacaval anastomosis. Effects of acute ammonia loading. J Neurochem 34: 1538, 1980
James JH, et al: Hyperammonemia, plasma amino acid imbalance, and blood-brain amino acid transport: A unified theory of portal-systemic encephalopathy. Lancet 74: 772, 1979
Livingstone AS. et al: Changes in the blood-brain barrier in hepatic coma after hepatectomy in the rat. Gastroenterology 73: 697, 1977
Parsons-Smith BG, et al: The electroencephalograph in hepatic coma. Lancet 2: 867, 1957
Pear EA, et al: Methionine toxicity in liver disease and its prevention by chlortetracycline. Clin Sci 15: 93, 1956
Ohigashi K, et al: The role of pyridoxal in methyl mercaptan formation-partial purification and resolution of methionine. Med J Osaka Univ 2: 111, 1951
Canellakis ES, et al: Studies on protein synthesis in vitro. IV. Concerning the apparent uptake of methionine by particulate preparation from liver. Arch Biochem Biophys 42: 387, 1953
McClain CT, et al: Blood methanethiol in alcoholic liver disease with and without hepatic encephalopathy. Gut 21: 318, 1980
Shults WT, et al: Methanethiol poisoning. JAMA 211: 2153, 1970
Waller RL: Methanethiol inhibition of mitochondrial respiration. Toxicol & Applied Pharmacol 42: 111, 1977
Quarfoth G, et al: Action of methanethiol on membrane (Na+, K+)-ATPase of rat brain. Biochem Pharmacol 25: 1039, 1975
Zieve L, Derr RF: Methanethiol and fatty acids depress urea synthesis by the isolated perfused rat liver. Gastroenterology 80: 1355, 1981
Fischer JE, et al: The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 80: 77, 1976
Freund H, et al: Chronic encephalopathy. Long-term therapy with branched-chain amino-acid-enriched elemental diet. JAMA 242: 347, 1979
Goldberg AL, et al: Regulation and significance of amino acid metabolism in skeletal muscle. Fed Proc 37: 2301, 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Higashi, T. Impaired metabolism of methionine in severe liver diseases II. Clinical and experimental studies on role of impaired methionine metabolism in pathogenesis of hepatic encephalopathy. Gastroenterol Jpn 17, 125–134 (1982). https://doi.org/10.1007/BF02774551
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02774551